Table 2.

Data sources

Data source	Description	Purpose
Data abstraction	▪ Data abstracted from clinical delivery tools	▪ Define who is initiating PrEP and whether persons are appropriately put on PrEP
Technical assistance	▪ TA reports prepared at baseline and 6-monthly	▪Document details of the process of adoption and integration of PrEP delivery and track changes in PrEP implementation processes. ▪ Rapid cycle analysis to convey to facilities for quality improvement
Qualitative interviews: user and provider	▪ Purposefully sampled patient and key informants involved in the delivery	▪ Gain deep understanding of process of adoption and integration of PrEP delivery and track changes in PrEP implementation processes.
Time and motion studies	▪ Primary data collection	▪ Economic evaluation
Exit interviews	▪ Random on spot user structured surveys at the end of clinic visit	▪ User experiences and satisfaction
Random blood draw	▪ Dried blood spots collected at ~ 10% visits on persons using PrEP	▪ Objective assessment of PrEP adherence (tenofovir levels), resistance surveillance
Observation	▪ Informal	▪ Track changes in PrEP implementation processes.